Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Indaptus Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||||
Primary Offering of Securities: | ||||||||||||||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock | 457 | (o) | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Preferred Stock | 457 | (o) | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Fees to Be Paid | Other | Subscription Rights | 457 | (o) | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Fees to Be Paid | Debt | Debt Securities | 457 | (o) | $ | — | $ | — | $ | — | — | $ | — | |||||||||||||||||||||||||||||||
Fees to Be Paid | Other | Warrants | 457 | (o) | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Units | 457 | (o) | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Fees to Be Paid | Unallocated (Universal) Shelf | (1) | 457 | (o) | $ | 200,000,000 | — | $ | 200,000,000 | 0.0000927 | $ | 18,540 | ||||||||||||||||||||||||||||||||
Fees to Be Paid | Total Registration Fee: | $ | 200,000,000 | N/A | $ | 200,000,000 | — | $ | 18,540 | |||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Total Offering Amounts | $ | 200,000,000 | $ | 18,540 | ||||||||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | $ | 18,540 | (3) | — | ||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 0 |
(1) | There is being registered hereunder an indeterminate number of shares of (a) common stock, (b) preferred stock, (c) subscription rights to purchase common stock, preferred stock or debt securities of the registrant (d) debt securities, (e) warrants to purchase common stock, preferred stock or debt securities of the registrant, and (f) units, consisting of some or all of these securities in any combination, as may be sold from time to time by the registrant. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. There is also being registered hereunder an indeterminate number of shares of common stock, preferred stock and debt securities as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance. In no event will the aggregate offering price of all types of securities issued by the registrant pursuant to this registration statement exceed $200,000,000. Pursuant to Rule 416 under the Securities Act of 1933, as amended, this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or pursuant to anti-dilution provisions of any of the securities. Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities. If any debt securities are issued at an original issue discount, then the offering may be in such greater principal amount as shall result in a maximum aggregate offering price not to exceed $200,000,000 after the date hereof. |
(2) | The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Item 16(b) of Form S-3 under the Securities Act. |
(3) | Represents the total of the fee offset claimed pursuant to Rule 457(p) under the Securities Act for the registration fee previously paid with respect to unsold securities, as set forth in Table 2. |
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | |||||||||||||||||||||||||||||
Rule 457(p)/b> | ||||||||||||||||||||||||||||||||||||||
Fee Offset Claims | Indaptus Therapeutics, Inc. | S-3 | 333-265350 | (1) | 06/01/2022 | - | $ | 18,540 | Unallocated (Universal Shelf) | $ | 200,000,000 | $ | 200,000,000 | |||||||||||||||||||||||||
Fee Offset Sources | - | - | - | - | - | - | - | - | $ | 18,540 |
(1) | Pursuant to Rule 457(p) under the Securities Act, $200,000,000 of the registration fee due in connection with this filing is hereby offset by the same amount in registration fees previously paid in connection with the registration statement of Indaptus Therapeutics, Inc. on Form S-3 (333-265350), which was initially filed on June 1, 2022 and withdrawn prior to the date of effectiveness pursuant to a request filed on July 1, 2022. No securities were sold with respect to the withdrawn registration statement. |